Sertraline Hydrochloride from Japan
Sertraline hydrochloride is a selective serotonin reuptake inhibitor (SSRI) used primarily as an antidepressant for treating major depressive disorder and anxiety disorders. As an aromatic monoamine derivative with amine-function characteristics, it falls under HTS 2921.49.38.00 specifically for psychotherapeutic agents.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.628.5%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Require FDA approval and Drug Master File (DMF) submission for active pharmaceutical ingredients (APIs)
• Ensure Certificate of Analysis (CoA) verifies purity >99% and absence of impurities per USP standards
• Avoid misclassification as general aromatic amines; specify psychotherapeutic end-use in documentation